Medicare Enrolled

Dr. Gary Lefkowitz, MD

Urology Physician · Freeport, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
155 W MERRICK RD, Freeport, NY 11520
5168670102
In practice since 2006 (20 years)
NPI: 1851335434 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lefkowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lefkowitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lefkowitz

Dr. Gary Lefkowitz is an urology physician in Freeport, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lefkowitz performed 10,496 Medicare services across 5,984 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lefkowitz received a total of $5,143 from 48 pharmaceutical and/or device companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lefkowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 8% volume in NY $5,143 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,496
Medicare services
Top 8% in NY for urology physician
5,984
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~525 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
2,719 $4 $12
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
2,035 $79 $313
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
744 $8 $9
PSA test (prostate cancer screening) 596 $18 $55
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
546 $10 $47
Urine culture, bacterial colony count
A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections.
471 $8 $24
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $49 $198
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
388 $104 $442
Antibiotic sensitivity test
A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods.
344 $8 $26
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
239 $46 $172
Bacterial culture, aerobic
A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms.
207 $8 $24
Urine culture, bacterial identification
A laboratory test that grows and identifies bacteria from a urine sample to detect infections.
207 $8 $24
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
201 $98 $394
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
158 $18 $55
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
149 $78 $291
Leuprolide acetate (for depot suspension), 7.5 mg 143 $133 $758
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
141 $233 $971
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
94 $57 $220
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
76 $22 $276
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
63 $73 $270
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
54 $33 $121
Simple change of bladder tube 53 $89 $446
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
47 $142 $1,443
Antimicrobial drug detection test
A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample.
44 $5 $14
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
38 $13 $49
Complicated insertion of bladder tube 37 $134 $535
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
32 $25 $77
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
28 $68 $591
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
27 $393 $1,438
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
23 $30 $227
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
23 $58 $253
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
22 $177 $2,936
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
20 $6 $126
Catheter specimen collection
A procedure to collect a specimen using a catheter. This service is available in all places of service.
18 $8 $9
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
16 $309 $1,305
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
16 $8 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $149 $579
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
14 $115 $446
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
13 $313 $1,244
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
11 $10 $32
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
6.8% medium
92.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,143
Total received (2018-2024)
Avg $735/year across 7 years
Top 31% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
257
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,917 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$226 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$617
2023
$656
2022
$963
2021
$734
2020
$325
2019
$873
2018
$975

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$105
Sumitomo Pharma America, Inc.
$74
COLOPLAST CORP
$62
Astellas Pharma US Inc
$51
Antares Pharma, Inc.
$46
Boston Scientific Corporation
$39
PFIZER INC.
$38
Verity Pharmaceuticals Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$27
Dendreon Pharmaceuticals LLC
$24
Telix Pharmaceuticals
$23
Tolmar, Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$19
Myriad Genetic Laboratories, Inc.
$19
Medtronic, Inc.
$18
ABC Home Medical Supply, Inc.
$17
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$696
Janssen Biotech, Inc.
$642
Teleflex LLC
$473
Dendreon Pharmaceuticals LLC
$433
PFIZER INC.
$369
Antares Pharma, Inc.
$241
Coloplast Corp
$227
PROCEPT BioRobotics Corporation
$205
Endo Pharmaceuticals Inc.
$165
Bayer HealthCare Pharmaceuticals Inc.
$142
Sumitomo Pharma America, Inc.
$117
Myovant Sciences Inc.
$99
Rochester Medical Corporation
$94
Bayer Healthcare Pharmaceuticals Inc.
$78
AbbVie, Inc.
$68
TOLMAR Pharmaceuticals, Inc.
$65
Boston Scientific Corporation
$65
Verity Pharmaceuticals Inc.
$62
COLOPLAST CORP
$62
NeoTract Inc.
$59
Ferring Pharmaceuticals Inc.
$56
Supernus Pharmaceuticals, Inc.
$48
Progenics Pharmaceuticals, Inc.
$43
Acerus Pharmaceuticals Corporation
$42
Clarus Therapeutics Inc.
$40
UROVANT SCIENCES INC
$39
Myriad Genetic Laboratories, Inc.
$39
ABBVIE INC.
$37
Tolmar, Inc.
$37
ABC Home Medical Supply, Inc.
$36
C. R. BARD, INC. & SUBSIDIARIES
$35
Blue Earth Diagnostics Limited
$33
UroGen Pharma, Inc.
$32
Avadel Specialty Pharmaceuticals, LLC
$27
Amgen Inc.
$24
Telix Pharmaceuticals
$23
DENTSPLY IH AB
$20
PROGENICS PHARMACEUTICALS, INC.
$19
ACCORD HEALTHCARE, INC.
$18
Zyla Life Sciences
$18
Medtronic, Inc.
$18
DENTSPLY IH Inc.
$16
Axonics, Inc.
$16
Hollister Incorporated
$15
Mission Pharmacal Company
$13
Allergan Inc.
$13
AbbVie Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$12
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
AMS · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axumin · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GEMTESA · GreenLight XPS · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · LUPRON DEPOT · LoFric · Luja Coude · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · SPEEDICATH · SPRIX · SpeediCath · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · VaPro · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Freeport?
Compare urology physicians in the Freeport area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
574
Per 100K population
41.4
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lefkowitz is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lefkowitz experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Lefkowitz performed 2,719 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lefkowitz receive payments from pharmaceutical companies?
Yes. Dr. Lefkowitz received a total of $5,143 from 48 companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lefkowitz's costs compare to other urology physicians in Freeport?
Dr. Lefkowitz's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lefkowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →